Cytosorbents Corporation engages in the research, development, and commercialization of medical devices.Its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. The company also develops VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals.
